Ohmichi M

No ORCID on file · 29 papers in corpus · active 2007-2022

Study types

  • article 14
  • other 2
  • review 1

Condition tags

  • endometriosis 17
  • endometrioma 5
  • infertility 3
  • chronic_pelvic_pain 1
2010
Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary.
Molecular cancer therapeutics ·doi:10.1158/1535-7163.mct-10-0169

This study examines the role of vascular endothelial growth factor (VEGF) as a therapeutic target in clear cell carcinoma (CCC) of the ovary, which has been regarded as a chemoresistant histologic subtype. Immunohistochemical analysis using…

2009
mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary.
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-09-0365

PurposeMammalian target of rapamycin (mTOR) plays a central role in cell proliferation and is regarded as a promising target in cancer therapy, including for ovarian cancer. This study aimed to examine the role of mTOR as a therapeutic targ…

article 2007
Mitochondrial gene expression in granulosa cells of severe endometriosis with in vitro fertilization and embryo transfer
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.01.111

The expression of mitochondrial genes in granulosa cells was quantitated by real-time polymerase chain reaction. The expression ratio of mitochondrial genes in granulosa cells of patients with severe endometriosis showed no statistically si…

article 2007
Survivin gene expression in granulosa cells from infertile patients undergoing in vitro fertilization–embryo transfer
Fertility and sterility ·doi:10.1016/j.fertnstert.2007.02.018

ObjectiveTo evaluate survivin gene expression in granulosa cells from infertile patients and examine the relationship between survivin gene expression and infertile clinical background.DesignProspective study.SettingIVF-ET program at Osaka …